51 – 60 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
beta-Microseminoprotein binds CRISP-3 in human seminal plasma
(
- Contribution to journal › Article
- 2004
-
Mark
Lead time associated with screening for prostate cancer
(
- Contribution to journal › Article
-
Mark
Isoformen des freien prostataspezifischen Antigens
(
- Contribution to journal › Article
-
Mark
An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6
(
- Contribution to journal › Article
-
Mark
Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio
(
- Contribution to journal › Article
- 2003
-
Mark
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
(
- Contribution to journal › Article
-
Mark
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
(
- Contribution to journal › Article
-
Mark
Quantitative PSA RT-PCR for preoperative staging of prostate cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
(
- Contribution to journal › Article
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
(
- Contribution to journal › Article